Detalles de la búsqueda
1.
Effect of heparin treatment on pulmonary embolism and in-hospital death in unvaccinated COVID-19 patients without overt deep vein thrombosis.
Thromb J;
20(1): 34, 2022 Jun 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-35725464
2.
Eltrombopag second-line therapy in adult patients with primary immune thrombocytopenia in an attempt to achieve sustained remission off-treatment: results of a phase II, multicentre, prospective study.
Br J Haematol;
193(2): 386-396, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33618438
3.
A brief rituximab, bendamustine, mitoxantrone (R-BM) induction followed by rituximab consolidation in elderly patients with advanced follicular lymphoma: a phase II study by the Fondazione Italiana Linfomi (FIL).
Br J Haematol;
193(2): 280-289, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33476434
4.
Eltrombopag for immune thrombocytopenia secondary to chronic lymphoproliferative disorders: a phase 2 multicenter study.
Blood;
134(20): 1708-1711, 2019 11 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-31570488
5.
Epilepsia partialis continua revealing idelalisib-associated PML-IRIS: clinical and pathological features.
J Neurovirol;
26(3): 437-441, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31807988
6.
Long-lasting efficacy and safety of lenalidomide maintenance in patients with relapsed diffuse large B-cell lymphoma who are not eligible for or failed autologous transplantation.
Hematol Oncol;
38(3): 257-265, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32356913
7.
Lenalidomide in Pretreated Mantle Cell Lymphoma Patients: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice (the Lenamant Study).
Oncologist;
23(9): 1033-1038, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29674440
8.
Nonpegylated liposomal doxorubicin combination regimen in patients with diffuse large B-cell lymphoma and cardiac comorbidity. Results of the HEART01 phase II trial conducted by the Fondazione Italiana Linfomi.
Hematol Oncol;
36(1): 68-75, 2018 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-28524259
9.
Italian real-life experience with brentuximab vedotin: results of a large observational study of 40 cases of relapsed/refractory systemic anaplastic large cell lymphoma.
Haematologica;
102(11): 1931-1935, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28775121
10.
Brentuximab vedotin in the treatment of relapsed/refractory CD30+ peripheral T-cell lymphoma: A FIL phase 2 study.
Hematol Oncol;
40(2): 307-309, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35023190
11.
Rituximab in immune thrombocytopenia: gender, age, and response as predictors of long-term response.
Eur J Haematol;
98(4): 371-377, 2017 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-27981682
12.
Thrombopoietin receptor agonists for preparing adult patients with immune thrombocytopenia to splenectomy: results of a retrospective, observational GIMEMA study.
Am J Hematol;
91(5): E293-5, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-26910388
13.
Second Neoplasms in Italian Patients with Hairy Cell Leukemia after Treatment with Cladribine: A Multicenter Investigation and Literature Review.
Cancers (Basel);
16(8)2024 Apr 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-38672557
14.
A BRAF-mutated case of hairy cell leukaemia lacking Annexin-A1 expression.
Br J Haematol;
183(5): 702, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30043467
15.
Bendamustine salvage therapy for T cell neoplasms.
Ann Hematol;
92(9): 1249-54, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23592272
16.
Bendamustine in chronic lymphocytic leukemia: outcome according to different clinical and biological prognostic factors in the everyday clinical practice.
Am J Hematol;
88(11): 955-60, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23861234
17.
Long-term follow-up of rituximab plus bendamustine and cytarabine in older patients with newly diagnosed MCL.
Blood Adv;
7(15): 3916-3924, 2023 08 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37171620
18.
Romidepsin-CHOEP followed by high-dose chemotherapy and stem-cell transplantation in untreated Peripheral T-Cell Lymphoma: results of the PTCL13 phase Ib/II study.
Leukemia;
37(2): 433-440, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36653509
19.
Salvage treatment with lenalidomide and dexamethasone in relapsed/refractory mantle cell lymphoma: clinical results and effects on microenvironment and neo-angiogenic biomarkers.
Haematologica;
97(3): 416-22, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22058200
20.
Second-line rituximab, lenalidomide, and bendamustine in mantle cell lymphoma: a phase II clinical trial of the Fondazione Italiana Linfomi.
Haematologica;
102(5): e203-e206, 2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28082342